A novel nitric oxide releasing prostaglandin analog, NCX 125, reduces intraocular pressure in rabbit, dog, and primate models of glaucoma.
about
Current understanding of conventional outflow dysfunction in glaucomaLocalized and Controlled Delivery of Nitric Oxide to the Conventional Outflow Pathway via Enzyme Biocatalysis: Toward Therapy for Glaucoma.Targeting Schlemm's Canal in the Medical Therapy of Glaucoma: Current and Future Considerations.Shear stress-triggered nitric oxide release from Schlemm's canal cellsPharmacotherapy of glaucoma.Nitric oxide-donating statin improves multiple functions of circulating angiogenic cells.Aqueous humor outflow: dynamics and disease.eNOS, a pressure-dependent regulator of intraocular pressure.Effect of nitric oxide compounds on monkey ciliary muscle in vitro.Role of nitric oxide in murine conventional outflow physiology.Endothelial nitric oxide synthase-related mechanotransduction changes in aged porcine angular aqueous plexus cellsTopical treatment of glaucoma: established and emerging pharmacology.Effect of nitric oxide on anterior segment physiology in monkeys.Medical treatment of glaucoma: present and future.Elevated hydrostatic pressures induce apoptosis and oxidative stress through mitochondrial membrane depolarization in PC12 neuronal cells: A cell culture model of glaucoma.Enhanced oxygen saturation in optic nerve head of non-human primate eyes following the intravitreal injection of NCX 434, an innovative nitric oxide-donating glucocorticoidA common humoral background of intraocular and arterial blood pressure dysregulation.gem-Dinitroalkyl Benzenes: A Novel Class of IOP-Lowering Agents for the Treatment of Ocular Hypertension.PHARMACOLOGICAL REGULATION OF OUTFLOW RESISTANCE DISTAL TO SCHLEMM'S CANAL.
P2860
Q26991731-C3F6C3C3-4931-4905-A015-3106AD3AEB58Q33589704-C7B78BA6-EF7E-465A-8CEF-9A46A0176BA8Q33665753-87C68C97-B7A3-47A9-A24E-75358FCBF81CQ34699955-A7866B0F-ED8C-4337-B908-C5B194175AEEQ35138049-9BA5C89D-005C-48D3-94E4-3FB911018FFBQ35287252-356962CE-02B5-467A-89F1-81C3EF0D63FCQ35608780-728E5E17-9F7F-40C7-B4D2-AC00A5F236E9Q35801497-A9369E40-1965-489C-9119-58D27F5BF6DFQ35820704-05B534A7-EBEE-4612-8400-3D14BB22C466Q35958562-EA1EEB2E-39B3-4D7D-948C-3D5710AAD65EQ35970421-CA33E43A-7442-4BF7-B5E4-235981354F00Q36365495-8142F410-2E4E-4F4C-BEB2-2AB868337742Q37059494-87779F67-DF00-49F0-A18E-AE21A106A506Q37870933-AA8CF22C-3464-4EA5-9BAA-5D5AE65749FDQ38997178-4C6CF8F4-FE3A-4C08-ADF1-45BE83B4751DQ41791333-EBDBC340-6A29-4AA7-A913-F764D15EC5DAQ50010662-1A693462-6D08-4C25-9EB4-94A8488EEDF0Q50066089-A319CAD5-8FA5-444C-866E-13E3A6FDADA6Q52598356-8483970F-8631-48F3-BA84-D1FBBA7B09DC
P2860
A novel nitric oxide releasing prostaglandin analog, NCX 125, reduces intraocular pressure in rabbit, dog, and primate models of glaucoma.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A novel nitric oxide releasing ...... nd primate models of glaucoma.
@ast
A novel nitric oxide releasing ...... nd primate models of glaucoma.
@en
A novel nitric oxide releasing ...... nd primate models of glaucoma.
@nl
type
label
A novel nitric oxide releasing ...... nd primate models of glaucoma.
@ast
A novel nitric oxide releasing ...... nd primate models of glaucoma.
@en
A novel nitric oxide releasing ...... nd primate models of glaucoma.
@nl
prefLabel
A novel nitric oxide releasing ...... nd primate models of glaucoma.
@ast
A novel nitric oxide releasing ...... nd primate models of glaucoma.
@en
A novel nitric oxide releasing ...... nd primate models of glaucoma.
@nl
P2093
P356
P1476
A novel nitric oxide releasing ...... nd primate models of glaucoma.
@en
P2093
Achim H P Krauss
Carol B Toris
David C Gale
David J Kucera
Elena Bastia
Ennio Ongini
Francesco Impagnatiello
Ganesh Prasanna
Massimiliano Guzzetta
P304
P356
10.1089/JOP.2009.0120
P577
2010-04-01T00:00:00Z